Replimune Group, Inc. (REPL)

7.04 -0.26 (-3.56%) USD  |  NASDAQ  |  Jan 16, 16:00
7.18 +0.14 (+1.99%) After-Hours: 20:00
More

Replimune Group EBITDA (TTM)

EBITDA (TTM) Chart

View EBITDA (TTM) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (TTM) Range, Past 5 Years

View EBITDA (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (TTM) Benchmarks

View EBITDA (TTM) Benchmarks
Start Trial
Rapt Therapeutics, Inc. Upgrade
Olema Pharmaceuticals, Inc. Upgrade
CorMedix, Inc. Upgrade
Verastem, Inc. Upgrade
Anavex Life Sciences Corp. Upgrade